CYNTHIA KIESEL: Open Payments
NPI 1558405753 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 24 payments from 11 companies in 2025. Trend: 2023 $430 · 2024 $483 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $99 |
| ABBVIE INC. | 5 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Amgen Inc. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Lundbeck LLC | 1 | $23 |
| Exact Sciences Corporation | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: VRAYLAR, HETLIOZ, TRINTELLIX, FANAPT, OTEZLA, XIFAXAN, Kerendia, QULIPTA.
Industry payments across IN — which companies pay providers there.
